leisure time -WSS

leisure time

author：hotspot 2025-09-02 11:45:28 - browse：1972

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Caregivers of transplant patients call for more support, training

WSS

GSK to buy asthma

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

DeSantis can now import cheaper drugs. But will Biden get credit?

The EU Joint Clinical Assessment needs to live up to its promise

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

STAT Summit: How a Chicago ER doctor tackles gun violence

hotspot

leisure time

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The EU Joint Clinical Assessment needs to live up to its promise

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New England Journal of Medicine addresses racist history, slavery

Moonlake's readout produced a cash windfall. Risks remain

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Novavax promises a turnaround & Lilly roils the obesity market

Senate committee scrutinizes Medicare Advantage brokers

What does generative AI mean for health care? We asked experts

HHS names first

hotspot

HHS leader on health, climate change and biopharma emissions

2023 STAT Wunderkinds: get to know the winners

Biotech reporter’s notebook: A sunnier mood at JPM 2024

New menopause drug shows promise in relief for hot flashes

Impact of Dobbs ruling felt at reproductive medicine meeting

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

leisure time

hotspot

Wikipedia

Wikipedia